Streetbeat News

RGC

Regencell Bioscience Holdings Limited

https://www.regencellbioscience.com

Industry

Drug Manufacturers - Specialty & Generic

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

U.S. stocks traded higher with the Dow Jones index gaining over 300 points. The trade deficit in the U.S. narrowed to $73.1 billion in June. VBI Vaccines, Regencell Bioscience, and Lumen Technologies saw significant stock price increases, while Elevation Oncology, Jumia Technologies, and ThredUp experienced notable declines.

Portfolio Pulse from Avi Kapoor

August 06, 2024 | 2:22 pm

Saia, Inc. (NASDAQ:SAIA) shares fell 18.6% after reporting worse-than-expected Q2 earnings and sales. Other notable movers include BurgerFi International, Inc. (NASDAQ:BFI) up 117.4% after a legal settlement, and DexCom, Inc. (NASDAQ:DXCM) down 40.7% due to disappointing Q2 revenue and weak FY24 guidance.

Portfolio Pulse from Avi Kapoor

July 26, 2024 | 5:26 pm

Edwards Lifesciences Corporation (NYSE:EW) shares fell sharply after reporting worse-than-expected Q2 sales and issuing weak Q3 guidance. Despite beating EPS estimates, the stock dipped 26.9%. The company also acquired JenaValve and Endotronix. Other notable movers include Predictive Oncology Inc. (NASDAQ:POAI), Psyence Biomedical Ltd. (NASDAQ:PBM), and Ford Motor Company (NYSE:F).

Portfolio Pulse from Avi Kapoor

July 25, 2024 | 6:12 pm

Indivior PLC (NASDAQ:INDV) shares surged 14.5% in pre-market trading after reporting better-than-expected Q2 earnings and announcing a $100 million share repurchase program. Other notable pre-market movers include Psyence Biomedical Ltd. (NASDAQ:PBM), BloomZ Inc. (NASDAQ:BLMZ), and 2U, Inc. (NASDAQ:TWOU), among others.

Portfolio Pulse from Avi Kapoor

July 25, 2024 | 10:36 am

Enphase Energy shares rose 6.2% in pre-market trading despite missing Q2 revenue and earnings estimates. Other notable pre-market movers include Dermata Therapeutics, NuZee, Regencell Bioscience, Allarity Therapeutics, NewGenIvf Group, Perfect Moment, ENGlobal Corporation, 1847 Holdings, and Seagate Technology among gainers, while Azitra, Conn’s, Verastem, ATI Physical Therapy, Volato Group, Chijet Motor, AtlasClear Holdings, Wheels Up Experience, SFL Corporation, and Tesla saw declines.

Portfolio Pulse from Avi Kapoor

July 24, 2024 | 9:27 am

Comcast Corporation (NASDAQ:CMCSA) shares fell 6.1% after reporting worse-than-expected Q2 sales results. Other notable stock movements include Azitra, Inc. (NYSE:AZTR) jumping 529% due to a new patent, and Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) rising 148% after advancing a study. General Motors Company (NYSE:GM) fell 6.1% after delaying EV projects.

Portfolio Pulse from Avi Kapoor

July 23, 2024 | 5:21 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. Mobile-health Network (MNDR) led the gainers with a 34.7% increase, while SeaStar Medical Holding (ICU) saw the largest decrease among the losers, dropping 21.2%. Other notable movers included NKGen Biotech (NKGN) and Kintara Therapeutics (KTRA) with substantial gains, and iSpecimen (ISPC) and AEON Biopharma (AEON) with notable losses. These movements reflect the dynamic nature of the healthcare stock market, influenced by factors such as quarterly earnings and market capitalization changes.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 4:31 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. Avalo Therapeutics led the gainers with a 364.8% increase, while Tonix Pharmaceuticals headed the losers with a 45.4% decrease. Other notable movers include Nexalin Technology and Biodexa Pharmaceuticals with substantial gains, and Kodiak Sciences and ENDRA Life Sciences among the losers, with their recent Q4 earnings reports influencing their stock prices.

Portfolio Pulse from Benzinga Insights

March 29, 2024 | 4:30 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. IMAC Holdings, Virios Therapeutics, Regencell Bioscience, Ontrak, Outlook Therapeutics, and Biolase were among the gainers, with IMAC Holdings leading with a 91.5% increase. On the downside, SINTX Techs, Nkarta, Cutera, 180 Life Sciences, Zura Bio, and Sangamo Therapeutics saw notable declines, with SINTX Techs dropping by 30.4%. Notably, Biolase, Nkarta, and Cutera's movements were influenced by their Q4 earnings reports.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 5:31 pm

In Wednesday's after-market session, health care stocks saw significant movements. Molina Healthcare led the gainers with a 24.2% increase, while Spruce Biosciences experienced the largest drop, declining by 75.2%. Other notable movers include Evoke Pharma, Aptorum Gr, and Galecto on the gainers' side, and Qilian Intl Hldg Gr, NuCana, and Regencell Bioscience among the losers.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 9:32 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.